Page 531 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

131. Kooter AJ, Ijzerman RG, Kamp O, et al. No effect of epopros- failure: the VERITAS randomized controlled trials. JAMA.
tenol on right ventricular diameter in patients with acute pul- 2007;298:2009-2019.
monary embolism: a randomized controlled trial. BMC Pulm 150. Amato MB, Barbas CS, Medeiros DM, et al. Beneficial effects
Med. 2010;10:18. of the “open lung approach” with low distending pressures in
132. Wang H, Gong M, Zhou B, et al. Comparison of inhaled and acute respiratory distress syndrome. A prospective randomized
intravenous milrinone in patients with pulmonary hypertension study on mechanical ventilation. Am J Respir Crit Care Med.
undergoing mitral valve surgery. Adv Ther. 2009;26:462-468. 1995;152:1835-1846.
133. Ziegler JW, Ivy DD, Wiggins JW, et al. Effects of dipyridamole 151. Puybasset L, Stewart T, Rouby JJ, et al. Inhaled nitric oxide
and inhaled nitric oxide in pediatric patients with pulmonary reverses the increase in pulmonary vascular resistance induced
hypertension. Am J Respir Crit Care Med. 1998;158:1388-1395. by permissive hypercapnia in patients with acute respiratory
134. Kinsella JP, Torielli F, Ziegler JW, et al. Dipyridamole augmenta- distress syndrome. Anesthesiology. 1994;80:1254-1267.
tion of response to nitric oxide. Lancet. 1995;346:647-648. 152. Mekontso Dessap A, Charron C, Devaquet J, et al. Impact of
acute hypercapnia and augmented positive end-expiratory
135. Wang L, Zhu du M, Su X, et al. Acute cardiopulmonary
effects of a dual-endothelin receptor antagonist on oleic acid- pressure on right ventricle function in severe acute respiratory
induced pulmonary arterial hypertension in dogs. Exp Lung distress syndrome. Intensive Care Med. 2009;35:1850-1858.
Res. 2004;30:31-42. 153. Jardin F, Brun-Ney D, Hardy A, et al. Combined thermodilution
136. Mikhail GW, Prasad SK, Li W, et al. Clinical and haemodynamic and two-dimensional echocardiographic evaluation of right
effects of sildenafil in pulmonary hypertension: acute and mid- ventricular function during respiratory support with PEEP.
term effects. Eur Heart J. 2004;25:431-436. Chest. 1991;99:162-168.
154. Pinsky MR, Desmet JM, Vincent JL. Effect of positive end-
137. Voswinckel R, Reichenberger F, Enke B, et al. Acute effects of expiratory pressure on right ventricular function in humans.
the combination of sildenafil and inhaled treprostinil on hae- Am Rev Respir Dis. 1992;146:681-687.
modynamics and gas exchange in pulmonary hypertension.
Pulm Pharmacol Ther. 2008;21:824-832. 155. Fougeres E, Teboul JL, Richard C, et al. Hemodynamic impact
138. Preston IR, Klinger JR, Houtches J, et al. Acute and chronic of a positive end-expiratory pressure setting in acute respiratory
distress syndrome: importance of the volume status. Crit Care
effects of sildenafil in patients with pulmonary arterial hyper- Med. 2010;38:802-807.
tension. Respir Med. 2005;99:1501-1510.
156. van den Berg PC, Jansen JR, Pinsky MR. Effect of positive
139. Ghofrani HA WR, Rose F, et al. Sildenal for treatment of lung pressure on venous return in volume-loaded cardiac surgical
fibrosis and pulmonary hypertension: a randomised controlled patients. J Appl Physiol. 2002;92:1223-1231.
trial. Lancet. 2002;360:895-900.
157. Pinsky MR. Determinants of pulmonary arterial flow variation
140. Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled during respiration. J Appl Physiol. 1984;56:1237-1245.
nitric oxide withdrawal. Anesthesiology. 1999;91:307-310.
141. Bigatello LM, Hess D, Dennehy KC, et al. Sildenafil can 158. Bouferrache K, Vieillard-Baron A. Acute respiratory distress
syndrome, mechanical ventilation, and right ventricular func-
increase the response to inhaled nitric oxide. Anesthesiology. tion. Curr Opin Crit Care. 2011;17:30-35.
2000;92:1827-1829.
159. Galie N, Hoeper MM, Humbert M, et al. Guidelines for
142. Schermuly RT, Leuchte H, Ghofrani HA, et al. Zardaverine and the diagnosis and treatment of pulmonary hypertension: the
aerosolised iloprost in a model of acute respiratory failure. Eur Task Force for the Diagnosis and Treatment of Pulmonary
Respir J. 2003;22:342-347. Hypertension of the European Society of Cardiology (ESC)
143. Namachivayam P, Theilen U, Butt WW, et al. Sildenafil prevents and the European Respiratory Society (ERS), endorsed by
rebound pulmonary hypertension after withdrawal of nitric the International Society of Heart and Lung Transplantation
oxide in children. Am J Respir Crit Care Med. 2006;174:1042- (ISHLT). Eur Heart J. 2009;30:2493-2537.
1047. 160. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart fail-
144. Siobal MS, Hess DR. Are inhaled vasodilators useful in acute ure treated with continuous-flow left ventricular assist device.
lung injury and acute respiratory distress syndrome? Respir N Engl J Med. 2009;361:2241-2251.
Care. 2010;55:144-157; discussion 157-161. 161. Tang DG, Oyer PE, Mallidi HR. Ventricular assist devices:
145. Afshari A, Brok J, Moller AM, et al. Inhaled nitric oxide for history, patient selection, and timing of therapy. J Cardiovasc
acute respiratory distress syndrome (ARDS) and acute lung Transl Res. 2009;2:159-167.
injury in children and adults. Cochrane Database Syst Rev. 162. Craig ML. Management of right ventricular failure in the era of
2010:CD002787. ventricular assist device therapy. Curr Heart Fail Rep. 2011;8:
146. Adhikari NK, Burns KE, Friedrich JO, et al. Effect of nitric oxide 65-71.
on oxygenation and mortality in acute lung injury: systematic 163. Chen JM, Levin HR, Rose EA, et al. Experience with right ven-
review and meta-analysis. BMJ. 2007;334:779. tricular assist devices for perioperative right-sided circulatory
147. Vachiery JL, Simonneau G. Management of severe pulmonary failure. Ann Thorac Surg. 1996;61:305-310; discussion 303-311.
arterial hypertension. Eur Respir Rev. 2010;19:279-287. 164. Reiss N, El-Banayosy A, Mirow N, et al. Implantation of the
148. Geiger R, Treml B, Kleinsasser A, et al. Intravenous tezosentan Biomedicus centrifugal pump in post-transplant right heart
and vardenafil attenuate acute hypoxic pulmonary hyperten- failure. J Cardiovasc Surg (Torino). 2000;41:691-694.
sion. High Alt Med Biol. 2008;9:223-227. 165. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive
149. McMurray JJ, Teerlink JR, Cotter G, et al. Effects of tezosentan of right ventricular failure after left ventricular assist device
on symptoms and clinical outcomes in patients with acute heart implantation. Am J Cardiol. 2010;105:1030-1035.

Section03-O-ref.indd 5 1/20/2015 7:10:27 AM